Toll-like receptors (TLRs) are key players in maintaining protection against any invading pathogen. These molecules are microbial sensing proteins which detect pathogen-associated molecular patterns and induce the body's innate immune system to elicit a response against invading pathogens. In addition to their role in pathogen recognition and elimination, these proteins are highly important in cancer biology and also play a variety of roles in normal to cancerous transformation or its prevention. There is much published literature on the role of TLRs in pathogen recognition and elimination, but recently the number of articles relevant to the role of TLR in carcinogenesis has increased due to their importance in this
area. On the one hand, they are involved in microbial elimination and, on the other hand, their modulation during cancer development has several implications. Accumulating a diverse thread of cancer-associated TLR modulation and infection susceptibility has several caveats. Some cancer-associated TLR modulation increases susceptibility to particular infections, while increased expression of certain TLR was found to help in the carcinogenic process through inducing inflammation. This article concludes that clinicians should consider TLR modulation during infection risk assessment in cancer patients. These modulations should also be considered while designing management strategies against cancer and its associated infections. Key words: cancer and microbes, infection, innate immunity, microbiology, chronic inflammation introduction A famous quote from Napoleon Bonaparte is 'The battlefield is a scene of constant chaos. The winner will be the one who controls that chaos, both his own and the enemies.' This is quite evident in host response to pathogens, where the host will have to manage regulated responses against pathogens. Lower than desired response may increase the chances for pathogen to take over the host, while the exaggerated response may lead to damage to one's own system in addition to that caused by the pathogen. This mechanism is also relatively apparent with the role of immunity in pathogen detection and cancer. Once after the infection, an innate component of immune system acts first and generates an inflammatory response to prevent any further entry of the pathogen. This response is followed by highly specific T and B cells to initiate specific adaptive immune responses against infection [1] . Toll-like receptors (TLRs) are an important component of the body's innate immune response. They recognize conserved molecular patterns found on a pathogen [known as pathogen-associated molecular pattern (PAMP)] or endogenous molecules released from self-cells following tissue damage or trauma (known as damage-associated molecular pattern) and initiate intracellular signaling to elicit response against them [2] . Therefore, TLRs are sensing proteins which detect any danger signal either through infection or from internal damage.
It is known already that certain microorganisms are associated with the development of cancer [3] [4] [5] . The microflora changes during cancer development are described in several studies and their role is suggested as a possible etiologic factor and potential diagnostic markers for cancer [6] . It is estimated that nearly 20% of all fatal cancers are due to microbial etiology [7] giving an indication toward substantial microbial involvement in carcinogenesis. In addition to microbial role in oncogenesis, the development of infectious complications in cancer patients is a major cause of morbidity and mortality. It is estimated that 60% deaths in patients with hematological malignancies are due to infectious complications. However, the data with solid organ tumors are not extensively available, but it is estimated that infections are either primary or an associated reason for deaths in 50% solid organ tumor patients. Cancer patients are susceptible to a wide variety of infectious diseases in which bacterial and fungal infections rank first and second respectively; however, viral and parasitic infections are also common and considered in susceptible individuals [8] . Some infectious complications are related to cytotoxic and immunosuppressive cancer chemotherapy while some cancers themselves are associated with immunodeficiency. For example, patients with chronic lymphocytic leukemia and myeloma are associated with hypogammaglobulinemia and have elevated susceptibility to infectious complications [9, 10] .
The changes in TLR expression with oncogenic transformation are evident in many studies and these cancer-associated TLR modulations can have substantial impact on any particular microbial infection. In this article, we briefly discuss TLR functional aspects in detection of danger, because a plethora of articles are available on this topic. Though the role of TLR in cancer is reviewed in many articles, the literature related to changes in infection susceptibility with cancer-associated TLR modulation is not available in detail. We thus aim to cover this issue for understanding cancer-associated TLR modulation and susceptibility to any particular infection. Due to the severe mortality and morbidity caused by microbial infections in cancer patients, we tried to gather information about TLR modulation and infection susceptibility in cancer patients.
structure of toll-like receptor
The toll-like receptors are categorized as type I integral membrane receptors with their N-terminal outside the membrane. They consist of N-terminal glycoprotein ectodomain (ECD) serving as the ligand recognition domain, a single transmembrane domain and a C-terminal cytoplasmic domain, involved in TLRmediated signaling and play an important role in signaling pathways through toll-IL1 receptor (TIR) domain [11] . However, TLRs using nucleic acid (NA) as ligand/pattern to detect pathogens have a multispan transmembrane protein (UNC93B) which targets these TLRs to endocytes [12] . The ECDs of TLR are made of tandem copy of 22-29 residues leucine-rich repeats (LRRs) separated by hydrophobic residues present at regular intervals [11, 13] .
Vertebrate TLRs are usually categorized into six subfamilies on the basis of sequence homology, including TLR1/2/6/10, TLR3, TLR4, TLR5, TLR7/8/9, TLR11/12/13/21/22/23, of which human do not have any functional member of TLR 11 subfamily. The ECD of TLRs varies in the number of LRRs and also of the glycosylation pattern even within different TLRs of humans. Although all the ECDs usually are present in the horse shoe shape structure, their curvature is variable in different types of TLR [13, 14] . Table 1 gives a general idea about TLR expression and their modulation during cancer. pathogens, known as PAMPs. The detection of these conserved PAMPs by TLR has many advantages. PAMPs are specific to the pathogen but not to the host which leads to some selective discrimination between self and non-self. PAMPs are involved in microbial survival, so the rates at which PAMPs change due to mutations are very low, which gives higher ability for the recognition of different pathogens. Due to the conserved nature of PAMPs, less number of pattern-recognition receptors are required to detect the presence of a pathogen [45, 46] . However, the later discovery of host-derived, extra domain A of the extracellular matrix protein fibronectin and heat shock protein as TLR ligands, indicated that TLRs actually do not distinguish between self and non-self, instead they only respond to danger signals, either from self or from non-self [47] . It has been found already that one TLR can recognize a variety of ligands. The recognition of pathogens by TLR has been reviewed in many articles. The ligands recognized by TLR are not unique to pathogens as normal microflora also express these ligands. Earlier, it was thought that pathogens have virulence factors which allow them to pass through epithelial barriers, where they get a chance to interact with TLR-expressing cells, whereas normal microflora organisms are sequestered by surface epithelia [48] . It was also suggested that disruption of mucosal barrier allows normal microflora to interact with TLR and contribute to inflammation. However, it was found later that the interaction of TLR with normal microflora-derived ligands protects from epithelial injury and maintains intestinal epithelial homeostasis. During a study, researchers gave LPS (TLR4 ligand) and lipoteichoic acid (LTA) (TLR2 ligand) in drinking water to microflora-free animals and induced intestinal injury by dextran sulfate sodium, but these commensal-derived LPS and LTA protected animals from injury. They also found that the interaction of TLR with commensal microorganisms regulates production of many protective factors [49] .
TLR signaling pathways: warning for host TLR signaling pathways involve adaptor proteins, including MyD88, TIRAP, TRIF, and TRAM, to initiate TLR-mediated signaling [50] [51] [52] , but these pathways are divided into two types, the TRIF-dependent and MyD88-dependent pathway.
MyD88-mediated pathway is used by every TLR except TLR3 [53, 54] . Ligand binding with TLRs leads to conformation changes in TLRs and TLRs recruit adaptor protein MyD88, which further recruits IRAK kinases including IRAK1 and IRAK4. These kinases either activate protein TRAF6 or can lead to apoptosis by caspase 8. TRAF6 protein polyubiquinates itself as well as protein TAK1 and binds to IKKβ. This protein activates after phosphorylation by TAK1, which in turn phosphorylates Iκ, leading to its degradation NF-κB/IκB complex and release of NF-κB in cytoplasm to induce transcription of various inflammatory cytokines [55] .
TRIF-mediated pathway works with TLR3 and TLR4. After binding of ligands, it recruits adaptor protein TRIF, which can recruit RIP1, TBK1, and TRAF3 kinases. TRIF/TBK1 complex phosphorylates IRF3, IRF7 which moves to nucleus and induces production of regulatory molecules, whereas TRIF/RIPK1 causes polyubiquitination and activation of TAK1 and NFκB similar to MyD88 pathway. TLR4 can use both pathways and uses all four adaptor proteins. TLR4/MD2/LPS complex recruits TIRAP and Inflammation is generally a protective response against invading pathogen or tissue injury, which leads to protection from infection or tissue repair; however, exaggerated inflammation leads to the development of a variety of diseases, including cancer [57] . The role of TLR in inflammation is reviewed in many articles, and it is suggested that a variety of factors regulate inflammatory response by TLR.
The expression level of TLR1 is found upregulated in an inflamed cell and a specific antibody against TLR1 is used to detect them. It is suggested that TLR1 is a most effective biomarker for the detection of inflammation [58] . Although, it has been observed that TLR2 can initiate renal inflammation during progressive renal injury [59] , but it is also observed that TLR2 is not required to initiate inflammatory bowel disease and TLR2-independent pathways exist for induction of chronic intestinal inflammation [60, 61] . Activation of TLR3 is also involved in a variety of inflammatory conditions including rheumatoid arthritis, airway inflammation, etc. [62] .
TLR 4 in association with MD2 is essential for the induction of responses against bacterial LPS and the production of inflammatory cytokines. Lipopolysaccharide binding protein (LBP) and CD14 are additional proteins facilitating LPS binding to TLR4/ MD2 complex. LBP is a soluble/plasma membrane protein, whereas CD14 is a glycosylphosphatidylinositol (GPI)-linked protein containing LRR which delivers the LPS-LBP complex to TLR4/MD2 complex [63] . TLR5 is also known to be an important factor in driving inflammatory response. It has been observed recently that microbes regulate the progression of malignancy through inflammation mediated by TLR5 [64] . The presence of TLR5 on intestinal epithelial cells also regulates the composition of intestinal microbiota and prevents inflammation-associated diseases, thereby playing a dual role in regulating inflammation [65] . TLR6 in combination with TLR4 is also known to mediate the inflammatory response after activation with amyloid-β and atherogenic lipids through CD36-mediated signaling [66] . Tolllike receptors 3, 7, 8, and 9 are involved in the recognition of NA, but chronic stimulation of these TLRs can also lead to the detection of self-NA and further damage to the host cell releasing more NA out of the cell. It can increase severity of the situation and may contribute to TLR-mediated oncogenic transformation [67] .
The segregation of TLR in the gut mucosa is suggested as an important factor in mediating a selective response against gut pathogens. In addition, trafficking of TLR within the cell is also suggested as a critical factor in regulating their selective response. TLRs 3, 7, 8, and 9 require an acidic environment to interact with NAs and therefore their interaction occurs at the endosomal compartment. This selective localization may also prevent recognition of ligands released by any self-damaged tissue which prevents the development of various autoinflammatory conditions. However, the same author has also suggested that this is not a universal phenomenon [68] . Inhibition of TLR signaling is also suggested as a critical factor in regulating a variety of inflammatory conditions, like reduced inflammatory response against microbes during tuberculosis and reduced risk of colitis-associated cancer by expression of TIR8 (a TLR family inhibitor of inflammation) [69, 70] . Therefore, microbes can regulate the development of cancer through a variety of mechanisms, including changes in metabolism, tumor microenvironment, and by induction of chronic inflammation and genotoxic response [71] . 
TLR modulation and cancer-associated infection
The role of TLR is evident in the development of cancer and many therapeutic interventions targeting TLR are being developed or are under investigation. The role of TLR modulation in cancer development has been already covered in detail [72] [73] [74] [75] , but the consequences of these changes in infection susceptibility are not covered frequently. Cancer patients are more prone to infections and immunosuppression because radical cancer therapy is suggested as a possible cause behind this susceptibility for a long time (Table 2 ) [96] . Detection of TLR modulation during cancer development and their major role in eliciting primary response against a pathogen indicates a more intricate association between TLR modulation, infection susceptibility, and oncogenic transformation (Figure 1 ).The next section is intended to cover TLR modulation during oncogenesis and their association with infection susceptibility. Cancer-associated TLR modulations range from up-or downregulation to SNP in certain TLRs. Single nucleotide polymorphism (SNP) is regarded as a very simple form of DNA variation, which may result in a change in amino acid codon, or no change, if occurring in noncoding region. A change in amino acid codon may result in altered gene expression, mRNA stability and even changes to subcellular localization of any protein [97] . The role of SNP in cancer risk has been discussed in several articles [98, 99] . SNPs are also found to modulate infection risk in a variety of diseases [100, 101] (Table 3) .
colon cancer
Colorectal cancer patients have increased expression of TLR1, 2, 4, and 8 mRNA [152] in comparison with normal individuals.
However, ulcerative colitis (UC), a risk factor for colon cancer, is found to have increased mRNA and protein expression of TLR2, TLR4, and TLR9, but not TLR1 and TLR3 [153] . UC has a multifactorial etiology, including an involvement of microbes. After a critical appraisal of studies on TLRs in colon cancer, it can be observed that during transformation from UC to colon cancer, further increased expression of TLR1 is found. As mentioned earlier, TLR1 acts as an important biomarker for inflammation; therefore, the microbiota dysbiosis associated with colorectal cancer (CRC) etiology and TLR1 overexpression indicates a role of microbe-mediated inflammation in its etiology.
In addition, TLR5 is also found to increase during the development of colorectal cancer (Table 1) , but a few studies also report two SNPs in TLR5 gene, one with increased survival and one with decreased survival in colorectal cancer patients [141] . TLR5 is important in maintaining the composition of gut microbiota and their absence is linked with the development of metabolic syndrome [154] . The TLR5 SNP related to colorectal cancer can predispose to infection susceptibility in affected patients and altered intestinal microbiome can contribute to persistent inflammation resulting in further colorectal cancer sequelae.
breast cancer
Several SNPs are found in a proportion of cases of breast cancer and prostate cancer. These SNPs are also known to increase susceptibility to a variety of infections (Table 3) . Prostheses are used to substitute surgically removed breast, and it has been found that Mycobacteria are a major cause of infection in breast prosthesis [155] . It is already found that the SNP can lead to the lack of surface TLR expression and increase the susceptibility of Mycobacterium infection ( associated TLR modulation needs careful evaluation by assessing infection susceptibility.
lymphoma
Gastric MALT lymphoma patients are prone to infections by Helicobacter pylori ( Table 2 ). The role of TLR1 polymorphism in increasing prevalence of H. pylori infection is already found [156] . Lymphoma-associated TLR1 SNPs can indicate the reason behind the increased susceptibility of H. pylori infection in lymphoma patients. However, this association is also suggested with an etiologic role [157] , but the role of the TLR1 SNP in increasing infection susceptibility indicates that this polymorphism provides an additional step for H. pylori infection which induces further oncogenic transformation. Genetic variations in TLR 2 and 5 genes are also responsible for H. pylori-associated gastric carcinogenesis [158] ; this is further supporting the notion that TLR2-related genetic variation will also affect ligand interaction by TLR2/6 complex. TLR6 is responsible for the detection of multiple diacyllipopeptides of Mycoplasma (Table 1) , and an increased susceptibility to Mycoplasma infection in gastric cancer patients is already evident [83] . TLR4 + 896G polymorphism is common in gastric cancer patients, and this polymorphism is also associated with increased susceptibility to infections. In addition, TLR2 SNPs are also found with increased risk of follicular lymphoma [120] . TLR1 in association with TLR2 recognizes a variety of ligands and therefore the SNP within their genes can indicate altered infection susceptibility in lymphoma patients. TLR2 (Arg753Gln allele) modulation is a common form of variation during CRC which is associated with marked infection susceptibility; however, its role in CRC etiology is not described [116] . Staphylococcus epidermidis is also known to cause septicemia in lymphoma patients although neutropenia is suggested as a possible factor behind increased prevalence of S. epidermidis, and the additional role of TLR 1 and 2 SNP cannot be ruled out.
The role of TLR in infection susceptibility is not necessarily true; sometimes, infections act as continuous stimuli for TLR activation, which lead to the generation of chronic inflammatory response resulting in cancer [159] . The association of Campylobacter jejuni with immunoproliferative small intestinal disease/alpha chain disease (a type of lymphoma) [76] (Table 2) , and the role of these bacteria in severe inflammation of intestinal mucosa [160] , indicates the involvement of TLR-mediated response for cancer development. This phenomenon is also associated with overexpression of various other TLRs ( Table 1 ). The overexpression of TLR2 in various cancers, including colon cancer and gastric cancer, which is now suggested to be caused by chronic inflammatory stimuli generated by microbes, indicates a possible role of increased inflammation by microbes in colorectal cancer etiology.
laryngeal carcinoma
In contrast to what has been discussed earlier, both MALT lymphoma and laryngeal carcinoma have shown reduction in TLR4 expression, which aids in the detection of lipopolysaccharide of gram-negative bacteria (Table 1) . This is further supported by a higher association of gram-negative bacterial infection, including Campylobacter jejuni, H. pylori, and Chlamydia psittaci in lymphoma patients, whereas infection of H. pylori is noted in laryngeal carcinoma patients. In addition, another TLR4 variation, TLR4 rs11536889 which is found in gastric and prostate cancer is found to increase susceptibility to infection (Table 3) .
prostate cancer
SNPs have been found in TLR6-TLR1-TLR10 gene cluster and this can also affect infection susceptibility in associated patients. TLR6 in association with TLR2 recognizes a variety of microbial ligands in order to elicit a response. Therefore, the reduction of TLR2 and TLR6 can have a mutual reduction in their activity. This is evident by the reduced activity of LTA detection by TLR2 alone after TLR6 SNP and resultant high prevalence of gram-positive bacteria Propionibacterium acnes in prostate tissues of men suffering from prostate disease [91] .
TLR7, 8, and 9 are chiefly responsible for the detection of NA of pathogens and TLR7 also responds to some antiviral drugs [161] . TLR9 SNPs are related to cervical cancer and Hodgkin's lymphoma [162, 163] . TLR9 is also responsible for the recognition of CpG oligodeoxynucleotide, which is present in microbes; the polymorphism in this molecule will affect its ability to recognize several microorganisms, and can increase susceptibility to infection. The Langerhans cells in cervical cancer have TLR7 and 8 which are anergic to their ligands and these cells lack TLR9 (Table 3 ). This situation clearly reflects that these conditions will predispose cancer patients to a variety of pathogens. TLR7-and TLR10-related modulations and subsequent infection risk are also discussed in Tables 1 and 3 , respectively. Although it is not possible to discuss all cancer-associated TLR modulation and altered infection susceptibility, Tables 1-3 aim to provide an overview on these events succinctly.
Cancer-associated TLR modulations do not always lead to elevated infection susceptibility. Sometimes, these infections are involved in the process of oncogenesis through TLR modulation. For example, H. pylori lipopolysaccharide has the ability to induce the expression of TLR4 and this modulation leads to proliferation of gastric epithelial cells through MEK1/2-ERK1/2 MAP kinase pathway [164] . As noted above, TLR5 agonist flagellin is a very important component in maintaining gut microbiota. The induction of TLR5 by flagellin can induce gastric cancer cell proliferation, thus emphasizing the role of microbial infection in oncogenesis through TLR modulation [165] . Sometimes, microbes-mediated TLR modulation can also affect treatment outcomes in cancer patients. For example, intestinal microbes can increase the dangerous effects of radiation in mouse colon by affecting MyD88-mediated TLR signaling pathway [166] . The role of TLR modulation in cancer development has already received much attention, but the idea behind increased infection susceptibility in cancer patients after TLR modulation is still untouched. This area is still in its infancy and many other microbial involvements in cancer development and infection susceptibility in cancer patients need to be investigated. Present research findings clearly indicate the dual role of TLR in cancer, including oncogenesis due to inflammation, as well as susceptibility to infection due to certain TLR modulations in cancer patients. The TLRs make important part of the innate immune system which recognizes invading pathogen. Their absence can prompt the development of infection, and damaged adaptive immune system components due to cancer-related host and therapeutic factors fairly support this hypothesis. 
Prostate cancer (−) [102] −3260C/T, −1692C/T −260A/G, 720A/C 1104A/C, 1417T/C 2322A/G Prostate cancer(+) [104] (-) decreased risk. 
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The information about TLR modulation and their impact on infection susceptibility can have a variety of implications. The management of cancer-associated infections is very important in patient care and several books and articles are available with respect to this [167] . The use of antimicrobial therapy for the management of these infections is a most common practice, but frequent development of antimicrobial resistance is creating additional complications. In addition, cancer patients are generally neutropenic and administration of prophylactic antibiotics is also a common practice among them; however, it has several disadvantages including development of antimicrobial resistance [168] . In such a situation, the identification of risk factor for cancer-associated infections can help in devising preventive and therapeutic management strategies. The knowledge of TLR modulation and its subsequent impact on infection risk can greatly help to find out an optimal prophylactic antibiotic regimen for cancer patients. This can reduce infection-associated mortalities in cancer patients. The modulation of TLR does not always increase infection susceptibility of certain microorganisms; some modulations lead to increased TLR stimulation, altered microbiota and resultant inflammation, which contribute to the development of cancer. Therefore, it has dual involvement in cancer where it can promote cancer or increase infection susceptibility. The clinicians should consider these modulations, while devising treatment strategies for cancer and its associated infectious complications. The cancerassociated TLR modulation and resultant change in host pathogen interaction needs a legitimate appraisal and can give profound impact on the cancer prevention and management of associated infectious complications. 
